Stereotaxis STXS
NYSE STXS
$1.30 -0.02 (-1.52%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026)

Stereotaxis' (STXS) quarterly Other Non-Current Liabilities came in at $5.1 million in Q1 2026, down 18.38% year-over-year from $6.3 million in Q1 2025, and up 8.13% quarter-over-quarter from $4.7 million in Q4 2025.

Analysis

Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Other Non-Current Liabilities for 17 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 18.38% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 18.38% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 22.89% from the prior year.
  • Other Non-Current Liabilities was $5.1 million for Q1 2026 at Stereotaxis, up from $4.7 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $7.0 million in Q3 2025 and troughed at $43000.0 in Q2 2023.
  • A 5-year average of $2.5 million and a median of $202000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities slumped 78.71% in 2023 and jumped 14453.49% in 2025, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $51000.0 in 2022, then declined by 15.69% to $43000.0 in 2023, then jumped by 14146.51% to $6.1 million in 2024, then decreased by 22.89% to $4.7 million in 2025, then rose by 8.13% to $5.1 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $5.1 million (Q1 2026), $4.7 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Stereotaxis 129.55 Mn 114.93 Mn 3.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.11 Mn
Dec 31, 2025 4.72 Mn
Sep 30, 2025 7.02 Mn
Jun 30, 2025 6.38 Mn
Mar 31, 2025 6.26 Mn
Dec 31, 2024 6.13 Mn
Sep 30, 2024 6.25 Mn
Jun 30, 2024 54,000.00
Mar 31, 2024 43,000.00
Dec 31, 2023 43,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 43,000.00
Mar 31, 2023 51,000.00
Dec 31, 2022 51,000.00
Sep 30, 2022 168,000.00
Jun 30, 2022 202,000.00
Mar 31, 2022 202,000.00
Dec 31, 2021 218,000.00
Sep 30, 2021 215,861.00
Jun 30, 2021 206,596.00